US 8623371
Targeting poly-gama-glutamic acid to treat Staphylococcus epidermidis and related infections
granted A61KA61K2039/6037A61K2039/6056
Quick answer
US patent 8623371 (Targeting poly-gama-glutamic acid to treat Staphylococcus epidermidis and related infections) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/6037, A61K2039/6056, A61K2039/6081, A61K39/085